Skip to main content
. 2025 Sep 25;12(10):1024. doi: 10.3390/bioengineering12101024
PPAR-γ Peroxisome proliferator-activated receptor gamma
TZDs Thiazolidinediones
DMF Dimethylformamide
PTSA Para-toluenesulfonic acid
Cs2 Carbon disulfide
ANOVA Analysis of Variance
SOCl2 Thionyl chloride
DCM Dichloromethane
PEG Polyethylene Glycol-600
POCl3 Phosphorus oxychloride
EtOH Ethanol
Nrf2 Nuclear factor erythroid 2
IBD Inflammatory bowel disease
NASH Non-alcoholic steatohepatitis
NAFLD Non-alcoholic fatty liver disease
DMD Duchenne muscular dystrophy
LGMD Limb-girdle muscular dystrophy
BMD Becker muscular dystrophy
GHR Growth hormone receptor
STAT5 Signal transduction/transcription activator 5
sIBM sporadic inclusion body myositis
TNF Tumor necrosis factor
IL Interleukin
AMY2A Amylase alpha 2A
GAA Glucosidase alpha, acid
PPARG Peroxisome proliferator-activated receptor gamma
PIK3CA Phosphatidylinositol 4,5-biphosophate 3-kinase catalytic subunit alpha
PRKCB Protein kinase C beta
INSR Insulin Receptor
EDG Electron donating group
EWG Electron withdrawing group
CALYX Cerebral adrenoleukodystrophy
SGLT-2 Sodium–glucose cotransport 2
DPP-4 Dipeptidyl peptidase-4
PEP-DM Pharmacophore enhanced pharmacodynamic modeling
CVD Cardiovascular disease